Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Qualitative Health Research|January 9, 2001
Best laid plans: examining contradictions between intent and outcome in a feminist, collaborative research projectD L GustafsonJournal of Veterinary Internal Medicine|March 27, 2010
Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transportersD L Gustafson, D H ThammJournal of the National Cancer Institute|August 5, 1992
Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumorsD L Gustafson, C A PritsosCancer Research|November 15, 1993
Kinetics and mechanism of mitomycin C bioactivation by xanthine dehydrogenase under aerobic and hypoxic conditionsD L Gustafson, C A PritsosOncology Research|January 1, 1994
Xanthine dehydrogenase and its role in cancer chemotherapyC A Pritsos, D L GustafsonChemico-Biological Interactions|October 20, 2001
Alterations in P-glycoprotein expression in mouse tissues by doxorubicin: implications for pharmacokinetics in multiple dosing regimensD L Gustafson, M E LongCancer Research|December 15, 1992
Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicumarolD L Gustafson, C A PritsosCancer Chemotherapy and Pharmacology|January 1, 1991
Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51D L Gustafson, C A PritsosBiochemical Pharmacology|August 18, 1992
PZ-51 (Ebselen) in vivo protection against adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicityC A Pritsos, M Sokoloff, D L GustafsonVeterinary and Comparative Oncology|July 4, 2012
Development of a limited-sampling model for prediction of doxorubicin exposure in dogsL A Wittenburg, D H Thamm, D L GustafsonPageof 5